SCHEMBL30453695

SCHEMBL30453695

COc1cccc(-c2cnc(C#N)c(Cl)c2C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.54
LRRK2 Q5S007 1/20 0.45
ADORA2A P29274 2/20 0.44
ADORA1 P30542 2/20 0.44
KDM4E B2RXH2 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
RXFP1 Q9HBX9 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 2/20 0.43
ALDH1A1 P00352 1/20 0.43
DYRK1A Q13627 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
TDO2 P48775 1/20 0.42
HTT P42858 2/20 0.42
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
XDH P47989 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257700 1.00 BTK (0.54) BTKLRRK2ADORA2AADORA1KDM4E
SCHEMBL24257773 0.88 BTK (0.44) BTKADORA2AADORA1NPSR1MEN1
SCHEMBL24257698 0.84 DHFR (0.44) LRRK2ADORA2AADORA1KDM4EMEN1
SCHEMBL30454648 0.84 DHFR (0.44) LRRK2ADORA2AADORA1KDM4EMEN1
SCHEMBL24257731 0.84 LRRK2 (0.42) BTKLRRK2ADORA2AADORA1KDM4E
SCHEMBL30453225 0.82 NPSR1 (0.41) BTKADORA2AADORA1KDM4ENPSR1
SCHEMBL24257730 0.82 NPSR1 (0.41) BTKADORA2AADORA1KDM4ENPSR1
SCHEMBL30546851 0.79 DHFR (0.43) BTKADORA2AADORA1KDM4ENPSR1
SCHEMBL24257623 0.79 DHFR (0.43) BTKADORA2AADORA1KDM4ENPSR1
SCHEMBL1162747 0.78 BTK (0.67) BTKLRRK2ADORA2AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196466-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2023-06-21 EP disclosed